| 摘要 |
FIELD: medicine. ^ SUBSTANCE: haemoglobin concentration in patient's peripheral blood, a systolic pressure value of a pulmonary artery, and an end-diastolic volume of a right ventricle of heart are evaluated. Then the value F is calculated by formula: F=175-27.3ùRVt-4.35ùSPPA+0.5ùH, where H is the peripheral blood haemoglobin concentration, g/l; RVt is the end-diastolic volume of the right ventricle of heart, cm; SPPA is the systolic pressure value of the pulmonary artery, mm Hg. If the value F>0 is observed, a positive clinical effect is predicted, and the value F <0 means a negative clinical effect or its absence. ^ EFFECT: application of the method allows prescribing the IGCSs only to those patients showing the positive clinical effect to be reached, promoting the improvement of medical aid quality to the COPD patient, and reduced undesired steroid load on the patient. ^ 2 ex |
